Cargando…

Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice

Abnormal amyloid-β (Aβ) accumulation is the most significant feature of Alzheimer’s disease (AD). Among the several secretases involved in the generation of Aβ, β-secretase (BACE1) is the first rate-limiting enzyme in Aβ production that can be utilized to prevent the development of Aβ-related pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Do, Jimin, Kim, Namkwon, Jeon, Seung Ho, Gee, Min Sung, Ju, Yeon-Joo, Kim, Jong-Ho, Oh, Myung Sook, Lee, Jong Kil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352815/
https://www.ncbi.nlm.nih.gov/pubmed/32599846
http://dx.doi.org/10.3390/ijms21124492
_version_ 1783557726738055168
author Do, Jimin
Kim, Namkwon
Jeon, Seung Ho
Gee, Min Sung
Ju, Yeon-Joo
Kim, Jong-Ho
Oh, Myung Sook
Lee, Jong Kil
author_facet Do, Jimin
Kim, Namkwon
Jeon, Seung Ho
Gee, Min Sung
Ju, Yeon-Joo
Kim, Jong-Ho
Oh, Myung Sook
Lee, Jong Kil
author_sort Do, Jimin
collection PubMed
description Abnormal amyloid-β (Aβ) accumulation is the most significant feature of Alzheimer’s disease (AD). Among the several secretases involved in the generation of Aβ, β-secretase (BACE1) is the first rate-limiting enzyme in Aβ production that can be utilized to prevent the development of Aβ-related pathologies. Cinnamon extract, used in traditional medicine, was shown to inhibit the aggregation of tau protein and Aβ aggregation. However, the effect of trans-cinnamaldehyde (TCA), the main component of cinnamon, on Aβ deposition is unknown. Five-month-old 5XFAD mice were treated with TCA for eight weeks. Seven-month-old 5XFAD mice were evaluated for cognitive and spatial memory function. Brain samples collected at the conclusion of the treatment were assessed by immunofluorescence and biochemical analyses. Additional in vivo experiments were conducted to elucidate the mechanisms underlying the effect of TCA in the role of Aβ deposition. TCA treatment led to improvements in cognitive impairment and reduced Aβ deposition in the brains of 5XFAD mice. Interestingly, the levels of BACE1 were decreased, whereas the mRNA and protein levels of three well-known regulators of BACE1, silent information regulator 1 (SIRT1), peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC1α), and PPARγ, were increased in TCA-treated 5XFAD mice. TCA led to an improvement in AD pathology by reducing BACE1 levels through the activation of the SIRT1-PGC1α-PPARγ pathway, suggesting that TCA might be a useful therapeutic approach in AD.
format Online
Article
Text
id pubmed-7352815
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73528152020-07-15 Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice Do, Jimin Kim, Namkwon Jeon, Seung Ho Gee, Min Sung Ju, Yeon-Joo Kim, Jong-Ho Oh, Myung Sook Lee, Jong Kil Int J Mol Sci Article Abnormal amyloid-β (Aβ) accumulation is the most significant feature of Alzheimer’s disease (AD). Among the several secretases involved in the generation of Aβ, β-secretase (BACE1) is the first rate-limiting enzyme in Aβ production that can be utilized to prevent the development of Aβ-related pathologies. Cinnamon extract, used in traditional medicine, was shown to inhibit the aggregation of tau protein and Aβ aggregation. However, the effect of trans-cinnamaldehyde (TCA), the main component of cinnamon, on Aβ deposition is unknown. Five-month-old 5XFAD mice were treated with TCA for eight weeks. Seven-month-old 5XFAD mice were evaluated for cognitive and spatial memory function. Brain samples collected at the conclusion of the treatment were assessed by immunofluorescence and biochemical analyses. Additional in vivo experiments were conducted to elucidate the mechanisms underlying the effect of TCA in the role of Aβ deposition. TCA treatment led to improvements in cognitive impairment and reduced Aβ deposition in the brains of 5XFAD mice. Interestingly, the levels of BACE1 were decreased, whereas the mRNA and protein levels of three well-known regulators of BACE1, silent information regulator 1 (SIRT1), peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC1α), and PPARγ, were increased in TCA-treated 5XFAD mice. TCA led to an improvement in AD pathology by reducing BACE1 levels through the activation of the SIRT1-PGC1α-PPARγ pathway, suggesting that TCA might be a useful therapeutic approach in AD. MDPI 2020-06-24 /pmc/articles/PMC7352815/ /pubmed/32599846 http://dx.doi.org/10.3390/ijms21124492 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Do, Jimin
Kim, Namkwon
Jeon, Seung Ho
Gee, Min Sung
Ju, Yeon-Joo
Kim, Jong-Ho
Oh, Myung Sook
Lee, Jong Kil
Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice
title Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice
title_full Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice
title_fullStr Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice
title_full_unstemmed Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice
title_short Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice
title_sort trans-cinnamaldehyde alleviates amyloid-beta pathogenesis via the sirt1-pgc1α-pparγ pathway in 5xfad transgenic mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352815/
https://www.ncbi.nlm.nih.gov/pubmed/32599846
http://dx.doi.org/10.3390/ijms21124492
work_keys_str_mv AT dojimin transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice
AT kimnamkwon transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice
AT jeonseungho transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice
AT geeminsung transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice
AT juyeonjoo transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice
AT kimjongho transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice
AT ohmyungsook transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice
AT leejongkil transcinnamaldehydealleviatesamyloidbetapathogenesisviathesirt1pgc1appargpathwayin5xfadtransgenicmice